Table 5 Adverse effects within 90 days after endovascular thrombectomy with/ without intravenous alteplase intervention
Adverse event | Cohorts | Comparisons | |
|---|---|---|---|
EA cohort | ET cohort | ||
Treatment(s) | Endovascular thrombectomy + intravenous alteplase intervention | Endovascular thrombectomy | |
Numbers of patients who underwent treatment | 184 | 141 | p-value |
Asymptomatic intracranial hemorrhage | 69 (38) | 45 (32) | 0.297 |
Symptomatic intracranial hemorrhage | 13 (7) | 5 (4) | 0.171 |
Infarction in new territory | 10 (5) | 7 (5) | 0.851 |
Large or malignant middle cerebral artery infarction | 25 (14) | 15 (11) | 0.424 |
Pneumonia | 15 (8) | 10 (7) | 0.723 |
Aspiration related event(s) | 12 (7) | 9 (6) | 0.959 |
Allergic reaction to contrast material | 2 (1) | 1 (1) | 0.725 |
Other adjudicated adverse effect(s) | 15 (8) | 11 (8) | 0.908 |